Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04565275
Title A Study of ICP-192 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Beijing InnoCare Pharma Tech Co., Ltd.
Indications

Advanced Solid Tumor

transitional cell carcinoma

cholangiocarcinoma

Therapies

ICP-192

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST